Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer

BACKGROUND: In the biopharmaceutical industry, biomarkers define molecular taxonomies of patients and diseases and serve as surrogate endpoints in early-phase drug trials. Molecular biomarkers can be much more sensitive than traditional lab tests. Discriminating disease biomarkers by traditional met...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Wang, Mu, Michael, Tran, Drabier, Renee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028860/
https://www.ncbi.nlm.nih.gov/pubmed/24565027
http://dx.doi.org/10.1186/1752-0509-7-S5-S8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028860/
https://www.ncbi.nlm.nih.gov/pubmed/24565027
http://dx.doi.org/10.1186/1752-0509-7-S5-S8

Ejemplares similares